CURE’s thyroid cancer page is an extensive resource of cancer information featuring the latest thyroid cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on thyroid cancer.
November 27th 2018, 8:46pm
Survivor diagnosed with second cancer after surgeon spots a lump on her throat while watching TV.
October 15th 2018, 7:06pm
The Food and Drug Administration has granted LOXO-292 a breakthrough therapy designation for the treatment of patients with advanced RET fusion–positive thyroid cancer who require systemic therapy, have progressed on prior treatment, and have no other acceptable alternative treatment options, according to a statement from Loxo Oncology, the developer of the selective RET inhibitor.
September 5th 2018, 9:37pm
The FDA has granted LOXO-292 a breakthrough therapy designation for the treatment of patients with RET fusion–positive non–small cell lung cancer (NSCLC) or RET-mutant medullary thyroid cancer (MTC). This designation will expedite the development and review of the drug.
August 16th 2018, 5:29pm
From genetic mutations to treatment behind bars, here's a roundup of our 2018 Summer issue.
August 9th 2018, 4:00pm
In this week’s episode of CURE Talks Cancer, we spoke with Voigt about how he noticed a lump in a woman’s neck while watching tv and utilized the power of social media to find her – which ultimately led to a thyroid cancer diagnosis.
August 1st 2018, 11:37pm
Instead of undergoing surgery for potential cancer, many people with thyroid nodules can safely opt for surveillance.
July 18th 2018, 6:33pm
High blood pressure is common in patients with thyroid cancer who are taking Lenvima. Here's what one expert says about managing it.
May 24th 2018, 5:23pm
Cancer survivors worry about recurrence, but seldom think about their risk for new primaries.
May 4th 2018, 9:07pm
The Food and Drug Administration (FDA) approved the two-drug combination Tafinlar (dabrafenib) and Mekinist (trametinib) to treat patients with metastatic or unresectable anaplastic thyroid cancer (ATC), whose tumors harbor the BRAF V600E mutation.
April 18th 2018, 8:54pm
After being diagnosed with a rare cancer, professional runner Gabriele Grunewald became inspired to start a nonprofit that raised awareness for other rare cancers and empowered those who have them.
Basal Cell Carcinoma Basics, From Diagnosis to Treatment
Stage 2 Cervical Cancer: Key Facts and Updates for Patients
HR+/HER2– Breast Cancer: Diagnosis and Treatment Guide
So You Want To Be A Cancer Advocate